Achieve Life Sciences (NASDAQ: IDXX) and IDEXX Laboratories (NASDAQ:IDXX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.
Institutional and Insider Ownership
7.5% of Achieve Life Sciences shares are owned by institutional investors. Comparatively, 91.2% of IDEXX Laboratories shares are owned by institutional investors. 7.0% of Achieve Life Sciences shares are owned by company insiders. Comparatively, 2.6% of IDEXX Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Volatility and Risk
Achieve Life Sciences has a beta of 1.93, suggesting that its stock price is 93% more volatile than the S&P 500. Comparatively, IDEXX Laboratories has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500.
This is a summary of current ratings and price targets for Achieve Life Sciences and IDEXX Laboratories, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Achieve Life Sciences||0||0||1||0||3.00|
Achieve Life Sciences currently has a consensus price target of $12.00, indicating a potential upside of 293.44%. IDEXX Laboratories has a consensus price target of $238.00, indicating a potential downside of 3.11%. Given Achieve Life Sciences’ stronger consensus rating and higher probable upside, analysts clearly believe Achieve Life Sciences is more favorable than IDEXX Laboratories.
Valuation & Earnings
This table compares Achieve Life Sciences and IDEXX Laboratories’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Achieve Life Sciences||$5.06 million||2.74||-$10.58 million||($22.10)||-0.14|
|IDEXX Laboratories||$1.97 billion||10.80||$263.14 million||$3.28||74.89|
IDEXX Laboratories has higher revenue and earnings than Achieve Life Sciences. Achieve Life Sciences is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.
This table compares Achieve Life Sciences and IDEXX Laboratories’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Achieve Life Sciences||N/A||-155.83%||-126.69%|
IDEXX Laboratories beats Achieve Life Sciences on 9 of the 14 factors compared between the two stocks.
Achieve Life Sciences Company Profile
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has a license agreement with Sopharma AD and University of Bristol. The company is headquartered in Bothell, Washington.
IDEXX Laboratories Company Profile
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.
Receive News & Ratings for Achieve Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achieve Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.